BioDelivery Services.

PositionTriangle - Brief Article

RESEARCH TRIANGLE PARK -- Newark, N.J.-based BioDelivery Services, which is developing drugs for cancer and other diseases, bought Arius Pharmaceuticals for $2.5 million in stock. Arius, which has three employees here, will operate as a BioDelivery subsidiary. It hopes to win U.S. Food and Drug Administration...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT